Monday, June 15, 2026

Korean Pharma in Trump’s Crosshairs: A 25% Tariff Threat—and Why U.S. Drug Prices Could Be the Real Risk

The U.S. plans a 25% tariff on Korean pharmaceuticals, raising concerns for both industries amid potential impacts on U.S. consumers.

How The New Spring of Baekhakbeol is Transforming Lives: Unveiling the Impact of North Korean Dramas on Rural Communities

North Korea's Rodong Sinmun highlights changes in residents living near the filming location of the popular drama 'Spring of Baekhak Valley.'

Sillajen Presents Early BAL0891 Clinical Findings at ASCO 2026, Highlighting Safety and Early Anti-Cancer Activity

ShillaGen presented initial clinical research results of its cancer drug BAL0891 at ASCO, showcasing promising developments.

Tag: Molecular Therapy

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Revolutionary Cancer Treatment SJ-650: What Makes It a Game Changer in Oncology?

SillaJen's SJ-650 cancer treatment platform gains recognition with publication in Molecular Therapy, showcasing its innovative approach and efficacy.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.